Ken Griffin Avanos Medical, Inc. Put Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$19.21 - $24.69 $80,682 - $103,698	-4,200 Reduced 45.65%	5,000 $120,000
Q1 2024 May 15, 2024	BUY	$17.97 - $22.68 $75,474 - $95,256	4,200 Added 84.0%	9,200 $183,000
Q4 2023 Feb 14, 2024	BUY	$17.64 - $22.99 $44,100 - $57,474	2,500 Added 100.0%	5,000 $112,000
Q3 2023 Nov 14, 2023	BUY	$19.93 - $26.31 $45,839 - $60,513	2,300 Added 1150.0%	2,500 $50,000
Q2 2023 Aug 14, 2023	SELL	$22.53 - $30.98 $27,036 - $37,176	-1,200 Reduced 85.71%	200 $5,000
Q1 2023 May 15, 2023	BUY	$26.92 - $31.75 $2,692 - $3,175	100 Added 7.69%	1,400 $41,000
Q4 2022 Feb 14, 2023	BUY	$19.88 - $27.37 $25,844 - $35,581	1,300 New	1,300 $35,000

275

42.5M

5.4K

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $865M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.